SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

TLSA.O (TLSA.O) News

Track canonical SquawkNews coverage tagged to TLSA.O, TLSA.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol TLSA.O Asset market Sector Markets 90 days 1 Updated Sep 21, 2026, 11:08 AM UTC Open live news feed
M Tiziana Life Sciences completes patient visits in MS drug trial Tiziana Life Sciences reported the last patient completed the final visit in its Phase 2a INFORM-MS trial of intranasal foralumab in progressive multiple sclerosis. Topline 12-week treatment results have not been present EQUITY | Sep 21, 2026, 11:08 AM UTC